Press Release Bristol Myers Squibb’s Application for Breyanzi (lisocabtagene maraleucel) Accepted for Priority Review by U.S. Food and Drug Administration (FDA) in Fifth Cancer Type for Relapsed or Refractory Marginal Zone Lymphoma (MZL) 4 August 2025
Press Release Mortgage Rates Drop to Lowest Level in 10 Months, Upping Purchasing Power in a Buyer-Friendly Market 4 August 2025
Press Release Citizens for Judicial Fairness Celebrates Introduction of Wheelspin in Delaware’s Chancery Court, a Historic Win for Chancery Reform Advocates 4 August 2025
Press Release Buildkite Names Software Industry Leader Kevin Gounden as CEO to Accelerate AI-Enabled Software Delivery 4 August 2025
Press Release Identiti Expands National Footprint and Manufacturing Capabilities with Acquisition of Cummings Resources 4 August 2025
Press Release Family Health Services of Darke County and AndHealth Celebrate Ribbon Cutting and Launch of Retail + Specialty Pharmacy at Expanded Greenville Location 4 August 2025
